Lecanemab can now be taken at home. So can the oversight that keeps it safe.
Adherence tracking and side-effect monitoring for patients with Alzheimer's disease who are self-administering subcutaneous lecanemab. Clinical teams keep the visibility they had in clinic, and patients and caregivers aren’t left to manage alone.
In clinic, risks are easier to see. At home, they can be missed.
Until now, lecanemab has required a clinic visit every two weeks. This created a natural checkpoint for clinicians to see how a patient is doing. When treatment is taken at home, that checkpoint disappears.
- Are patients adhering to their weekly injection?
- Are side effects emerging?
- Are patients' symptoms changing?
Missing any of these can mean that patients with Alzheimer's disease remain on a treatment that isn't effective, safe, or manageable in their daily life.
Everything a clinical team, patient and caregiver needs to support lecanemab treatment at home.
On schedule, safely.
A clear treatment adherence schedule, guided injection support in-app, and regular side-effect monitoring through patient and caregiver reporting.
A companion for caregivers.
The Kneu app guides caregivers through each weekly injection and makes it easy to log doses and any side effects, so they're supported at every step rather than left to manage treatment alone.
Richer insight, from home.
Real-time data on adherence, safety, objective cognitive performance and symptoms gives clinical teams more visibility than they had in clinic, creating a longitudinal view between visits and MRIs.
Three steps to safe treatment at home
- 1
Patient self-administers at home
Guided injection support in the Kneu app walks patients and caregivers through each weekly dose.
- 2
Doses and symptoms logged
Quick digital check-ins capture adherence and side effects as they happen.
- 3
Clinical team sees it all, in real time
Adherence, safety alerts, cognitive performance and symptom data flow straight to the care team, so changes that need a closer look aren't missed.
Better oversight for clinical teams is possible – even from the comfort of a patient's own home.
Most home-treatment support stops at reminders. Kneu combines adherence tracking, cognitive performance assessment and side-effect monitoring in one place, so clinical teams can keep watching for the changes that matter.
On track, automatically.
A treatment adherence schedule with dosing reminders and missed-dose flags sent straight to the clinical team.
Changes, monitored not missed.
Regular digital assessments plus patient-reported symptoms, so changes in cognitive performance or emerging side effects are picked up promptly.
A richer picture, from home.
Real-time data on adherence and safety gives clinical teams the same insight they had in clinic.
What our clinical lead says
“Home treatment only works if it's properly supported. Patients and caregivers need training and reassurance, and clinicians still need to know treatment is being taken correctly, and that side effects or complications are recognized promptly and escalated appropriately.”
Peace of mind for families.
Caregivers know they'll be alerted if something needs attention, not left to guess.
Confidence for clinical teams.
Compliance and safety data land in one place, without chasing patients for updates.
See how Kneu supports at-home lecanemab treatment
Book a short demo and we'll walk your team through it.
Book a demo